Holen Sie sich die Stockscreener-App
1.20
11.11%
0.12
Handel nachbörslich:
1.16
-0.04
-3.33%
Pyxis Oncology Inc Aktie (PYXS) Neueste Nachrichten
Pyxis Oncology shareholders elect three directors at annual meeting - Investing.com
Pyxis Oncology Elects New Directors at Annual Meeting - TipRanks
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Ameriprise Financial Inc. Takes $35,000 Position in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Jane Street Group LLC Grows Stake in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Nuveen Asset Management LLC Cuts Stake in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology, Inc. (NASDAQ:PYXS) Shares Sold by Deutsche Bank AG - Defense World
ProShare Advisors LLC Makes New Investment in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Northern Trust Corp Sells 15,449 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology Reports Increased Losses Amidst Ongoing R&D Investments - TipRanks
Millennium Management LLC Has $4.65 Million Stock Holdings in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $9.00 Consensus PT from Analysts - Defense World
HC Wainwright Weighs in on Pyxis Oncology Q1 Earnings - Defense World
Q2 EPS Estimates for Pyxis Oncology Cut by HC Wainwright - Defense World
Leerink Partnrs Comments on Pyxis Oncology FY2029 Earnings - Defense World
Pyxis Oncology’s (PYXS) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Pyxis Oncology (PYXS) Receives Reiterated Buy Rating from Analys - GuruFocus
Dimensional Fund Advisors LP Raises Position in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology : May 2025 Corporate Deck (9474da) - marketscreener.com
Pyxis Oncology Reports Q1 Loss and Business Update - TipRanks
Pyxis Oncology (PYXS) Advances Cancer Treatment Research | PYXS Stock News - GuruFocus
Pyxis Oncology, Inc. SEC 10-Q Report - TradingView
Pyxis Oncology Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Pyxis Oncology : May 2025 Corporate Deck (c8a9bd) - marketscreener.com
Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update - marketscreener.com
Pyxis Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Barclays PLC Purchases 12,924 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology to Participate in Two Upcoming Investor Conferences - The Manila Times
Pyxis Oncology, Inc. CEO Lara S. Sullivan to Participate in Upcoming Investor Conferences - Nasdaq
Next-Gen Cancer Drug Developer Pyxis Oncology Sets Major Investor Conference Schedule for May-June - Stock Titan
Pyxis Oncology (PYXS) Projected to Post Quarterly Earnings on Tuesday - Defense World
New Approaches to Tumor Targeting Are Driving the Next Wave of Oncology Breakthroughs - Baystreet.ca
Renaissance Technologies LLC Acquires 133,018 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology Inc (PYXS) is a good investment, but the stock may be overvalued - uspostnews.com
Taking a look at what insiders are doing to gauge the Pyxis Oncology Inc (PYXS)’s direction - knoxdaily.com
Pyxis Oncology reveals promising preclinical data for cancer drug - Investing.com
Pyxis Oncology reveals promising preclinical data for cancer drug By Investing.com - Investing.com UK
Pyxis Oncology Highlights Promising Preclinical Data for Micvotabart Pelidotin (MICVO) in Cancer Therapy at AACR 2025 - Nasdaq
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC - TradingView
Novel Cancer Drug Shows 91% Tumor Inhibition in Breakthrough Study | PYXS Stock News - Stock Titan
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics - Zacks Investment Research
Pyxis Oncology Inc (PYXS) requires closer examination - uspostnews.com
5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms - Yahoo Finance
Pyxis Oncology Inc (PYXS) receives a Mkt perform rating from William Blair - knoxdaily.com
Pyxis Oncology Inc (PYXS) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Top Cancer Stocks to Buy to Boost Your Portfolio's Health - Yahoo Finance
Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace
Sei Investments Co. Acquires New Position in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
American Century Companies Inc. Has $468,000 Stake in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pyxis Oncology, Inc. (NASDAQ:PYXS) - marketscreener.com
Pyxis Oncology stock plunges to 52-week low of $0.86 - Investing.com Australia
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):